Aspen Aerogels (NYSE:ASPN) Issues Q1 2025 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of -0.180-0.000 for the period, compared to the consensus EPS estimate of 0.080. The company issued revenue guidance of $75.0 million-$95.0 million, compared to the consensus revenue estimate of $104.2 million.

Aspen Aerogels Price Performance

Shares of Aspen Aerogels stock traded down $3.15 during midday trading on Thursday, hitting $8.60. 5,807,017 shares of the company were exchanged, compared to its average volume of 1,773,958. The firm has a 50 day simple moving average of $12.36 and a 200-day simple moving average of $18.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The firm has a market cap of $705.96 million, a P/E ratio of 874.17 and a beta of 2.14. Aspen Aerogels has a 52 week low of $8.55 and a 52 week high of $33.15.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. Research analysts forecast that Aspen Aerogels will post 0.12 earnings per share for the current year.

Wall Street Analyst Weigh In

ASPN has been the topic of a number of recent analyst reports. Roth Mkm reduced their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research report on Saturday, February 8th. Piper Sandler reduced their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a report on Thursday, January 16th. Finally, HC Wainwright reissued a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $29.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.